Schedule (route) |
Endpoint |
Vehicle |
Dose |
Treated/Control (%) |
Observations |
Q01DX009 (ip) |
median survival time |
saline |
0.4 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
0.8 mg/kg/injection |
142.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
1.6 mg/kg/injection |
120.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
3.2 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
Q01DX009 (ip) |
median survival time |
saline |
6.4 mg/kg/injection |
0.0 |
Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |